NSE/DEEPAKNTR

DEEPAKNTRDeepak Nitrite Ltd

Chemicals · NSE

₹1,538.1+0.29%

52-wk low52-WEEK RANGE52-wk high

₹1,286.8+19.5% from low ·-27.4% from high₹2,118.5

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

DEEPAKNTR-14.90% · 1Y

Range high ₹2,174Range low ₹1,280Latest ₹1,538.1252 bars · daily-close · NSE bhavcopy + 10Y history

ChemicalsMidcapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite38/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -23.9% — underperformer
· Below 200-DMA (-8.9%) — downtrend

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 39.0 close to sector median 38.2
· P/B 3.76 below sector median 4.34

Growth

Medium

Steady but not standout growth.

· Revenue YoY +204.0% — strong top-line
· Profit YoY -36.2% — earnings slipping

Profitability

Low

Profitability is a concern.

· ROE 9.7% — weak returns on equity
· Net margin 3.3% — thin margins

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeC(56/100)

Durability

75/100

Financially resilient — strong quality + solvency profile.

Show 4 drivers

Piotroski F-score5/9 (56pt)
Altman Z" score6.53 (100pt)
Debt/Equity0.22 (100pt)
ROE9.7% (39pt)

Valuation

51/100

Trading at a premium — growth must keep delivering to justify.

Show 4 drivers

P/E vs sector (39.0 / 38.2)102% (59pt)
P/B3.76 (70pt)
Dividend yield0.49% (12pt)
EV/EBITDA23.6 (33pt)

Momentum

42/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-23.9% (0pt)
DMA-trend alignmentsideways (50pt)
RSI (14)63.4 (92pt)
Price vs 200-DMA-9.1% (42pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)38.97

FAIR

CheapestP/E 39.0 near sector median.Most expensive

P/B3.76

FAIR

CheapestP/B 3.76 at 46th %ile of sector.Most expensive

EV/EBITDA23.64

OVERVALUED

Monthly seasonality

Avg monthly return over 10 years · historical — not a forecast

Best: Apr +9.06% · Worst: Oct -2.09%

Jan

+0.7%

40% win

Feb

+1.8%

40% win

Mar

+3.9%

60% win

Apr

+9.1%

80% win

May

+1.5%

50% win

Jun

+1.2%

Monthly return distribution

Distribution of 120 monthly returns

Mean

+3.22%

Median

+2.73%

Std dev

11.41%

Best

+40.9%

Worst

-20.4%

% positive

55%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 2

Lean balance sheet (D/E 0.22)
Low leverage means earnings are less sensitive to rate cycles
Bankruptcy risk low (Altman Z″ 6.53)
Z″ above 2.60 sits squarely in the 'safe' zone

WEAKNESSES · 1

Low return on equity (9.7%)
Below 10% ROE suggests inefficient use of shareholder capital

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 1

Profit contracting sharply (-36.2% YoY)
Double-digit earnings decline pressures valuation compression

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+0.3%

+5.2%

+6.2%

-4.8%

-16.5%

-15.9%

-4.9%

+0.0%

10Y

+36.4%

Fundamentals

VALUATION

Market cap

₹20,767 Cr

P/E (TTM)

39.0

P/E (fwd)

29.4

next 12m

P/B

3.76

EV/EBITDA

23.6

Book value

₹404.66

per share

PROFITABILITY · QUALITY

ROE

9.7%

ROCE

—

Net margin

3.3%

Op margin

7.8%

Gross margin

22.0%

D/E

0.22

GROWTH · MARKET

Rev YoY

+204.0%

Profit YoY

-36.2%

Div yield

0.49%

Payout

19.2%

52w change

-23.9%

Beta

0.17

defensive

Pros and cons

Auto-derived from ratios · not a buy/sell recommendation

PROS · 2

+Forward P/E materially below trailing (29.4x vs 39.0x)Street expects earnings growth that compresses the multiple — positive surprise cushion
+Revenue growing at +204.0% YoYGrowth-category territory — implies market-share gains or market expansion

CONS · 2

−Low ROE of 9.7%Below the 10%+ threshold most quality-focused investors require
−Down -23.9% over the last yearSignificant underperformance — could be opportunity or warning depending on fundamentals

Sector-relative context

Chemicals · 13 peers

P/E (TTM)

This stock

38.97

Sector median

38.18

Rank 7/13 (54th %ile)

ROE

This stock

9.7%

Sector median

13.4%

Rank 7/13 (54th %ile)

P/B

This stock

3.76

Sector median

4.34

Rank 6/13 (62th %ile)

Quality score · Piotroski F-score

5 / 9

Decent quality — clears Piotroski bar

✓Profitable (positive net income)· Most basic check — company makes money
✓Positive return on assets· Assets generate returns
✓Positive operating cash flow· Profits are backed by real cash, not accruals
✗Operating CF exceeds net profit· Healthy cash conversion — no aggressive revenue recognition
✗Long-term debt decreased YoY· Deleveraging — lower refinancing risk
✓ROA improved YoY· Getting more productive with the asset base
✓Operating margin expanded YoY· Pricing power or cost discipline
✗

Forensic score · Altman Z″ (emerging markets)

Bankruptcy-risk predictor · 1995 Altman emerging-market revision

SAFE6.53

Z″ = 6.53 — well inside the SAFE zone. Low bankruptcy risk signal across liquidity, profitability and solvency inputs.

Component	Ratio	Weight	Contribution
Working Capital / Total Assets (A)	0.076	×6.56	0.502
Retained Earnings / Total Assets (B)	0.627	×3.26	2.043
EBIT / Total Assets (C)	0.324	×6.72	2.178
Book Equity / Total Liabilities (D)	1.724	×1.05	1.811

Zones: Z″ ≥ 2.60 safe · 1.10–2.60 grey · < 1.10 distress. All four inputs derived from latest annual filing.

Analyst consensus

18 analysts · HOLD

Target mean

₹1703.89

Target high

₹2070.00

Target low

₹1130.00

Upside vs today

+11.9%

Street consensus target is +11.9% vs current price. Consensus is a lagging sentiment read, not a forecast.

Company + balance sheet snapshot

Industry

Chemicals

Employees

1,757

Shares out

13.6

Revenue (TTM)

₹7,946 Cr

EBITDA

₹927 Cr

Total debt

₹1,244 Cr

Cash

₹339 Cr

Net debt

₹905 Cr

Quarterly results

Last 6 quarters · ₹ Cr (Screener.in-grade depth)

Metric	2024-Q3	2024-Q4	2025-Q1	2025-Q2	2025-Q3	2025-Q4
Revenue	—	1,903	1,989	1,890	1,902	1,975
Operating profit	—	120	277	138	151	153
OPM %	—	6.3%	13.9%	7.3%	7.9%	7.8%

Annual P&L

Last 4 years · ₹ Cr · all line items

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Revenue	6,773	7,883	7,610	8,091
Operating profit	1,436	1,130	990	908
OPM %	21.2%	14.3%	13.0%	11.2%
Interest	34	25	12	28
Depreciation

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
DEEPAKNTRTHIS Deepak Nitrite Limited	₹1,538.1	-23.8%	20,767	39.0	3.76	9.7%	0.22	+204.0%
PIDILITIND Pidilite Industries Limited	₹1,393.4	-53.9%	1,41,522	62.0	14.82	23.9%	0.04	+10.1%
SRF SRF Limited	₹2,494.5	-17.7%	73,067	41.0	5.51	13.4%	0.35	+6.3%
COROMANDEL Coromandel International Limited	₹2,050.2	-6.7%	60,568	25.3	4.97	19.6%	0.12	+9.2%
PIIND PI Industries Limited	₹3,139.7	-14.8%	47,028	32.4	4.34	—	0.02	+4.1%
NAVINFLUOR Navin Fluorine International Limited	₹6,284	+49.1%	32,747	59.0	9.05	—	0.33	+13.8%
ATUL Atul Limited	₹6,600	+10.5%	19,356	32.6	3.27	10.1%	0.03	+18.1%
AARTIIND Aarti Industries Limited	₹440.85	+4.6%	16,067	42.6	2.82	6.6%	0.70	+14.1%
FINEORG Fine Organic Industries Limited	₹4,907.5	+13.9%	14,852	37.4	6.00	16.0%	0.01	+13.0%

ASK AXEL

Dig deeper into DEEPAKNTR

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for DEEPAKNTR — all in one sourced reply.

Ask free in chat

Run these tools on DEEPAKNTR

Historical return →

"If I had bought DEEPAKNTR in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on DEEPAKNTR

Brokerage + charges →

All-in cost for trading DEEPAKNTR

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	9.10	8.00	-12.1%
-2q	8.20	8.71	+6.2%
-3q	11.64	8.23	-29.3%
-4q	10.74	14.84	+38.1%

Date	Amount
2025-08-04	₹7.50
2024-07-29	₹7.50
2023-07-27	₹7.50
2022-07-25	₹7.00
2021-07-20	₹5.50
2020-03-16	₹4.50
2019-06-19	₹2.00
2018-07-25	₹1.30
2017-06-15	₹1.20
2016-07-28	₹1.20

Metric	2022-FY	2023-FY	2024-FY	2025-FY
Equity capital	27	27	27	27
Reserves	2,777	3,528	4,235	4,827
Borrowings	315	73	286	1,267
Total liabilities	4,430	5,129	6,096	7,718
Fixed assets	2,057	2,275	3,057	4,109
CWIP	124	362	813	1,709
Investments	2	2	3	3
Other assets	0	0	148	0
Total assets	4,430	5,129	6,096	7,718

Metric	2022-FY	2023-FY	2024-FY	2025-FY
CF Operating	824	650	874	625
CF Investing	-424	-276	-718	-1,491
CF Financing	-386	-359	44	806
Net cash flow	14	15	200	-59
Free cash flow	637	289	106	-512

Metric	2025-FY	2024-FY	2023-FY	2022-FY
OPM %	11.2%	13.0%	14.3%	21.2%
Net margin %	8.6%	10.7%	10.8%	15.7%
ROE %	15.3%	20.7%	26.8%	38.0%
ROCE %	18.4%	27.2%	34.7%	47.1%
Debt / Equity	0.26	0.07	0.02	0.11
Interest coverage	35.6×	94.1×	47.2×	43.1×
Revenue growth YoY	+6.3%	-3.5%	+16.4%	—
Profit growth YoY	-14.0%	-4.8%	-20.1%	—

DEEPAKNTRDeepak Nitrite Ltd

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Peer comparison · Chemicals

Ask Axel about DEEPAKNTR

Recent news

Dig deeper into DEEPAKNTR

Run these tools on DEEPAKNTR

Technical snapshot

Earnings history + surprises

Dividends + splits history

Stock scorecard

SWOT analysis

Recent news

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Analyst consensus

Company + balance sheet snapshot

Quarterly results

Annual P&L

Balance sheet

Cash flow statement

Ratios

Peer comparison · Chemicals